NUVISAN GmbH

company

About

NUVISAN GmbH provides product development and support services to the pharmaceutical, biotechnology, and medical device industries.

  • Neu-ulm,Bayern,Germany
  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$9.60M
Industries
Medical,Pharmaceutical,Therapeutics
Founded date
Jan 1, 1979
Number Of Employee
1 - 10
Operating Status
Active
Also Known As
AAIPharma Deutschland GmbH & Co. KG

Nuvisan Pharma Services is a global provider of product development and
support services to the pharmaceutical, biotechnology and medical device
industries. We deliver services ranging from a single test to fully integrated
drug development programs.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$9.60M
NUVISAN GmbH has raised a total of $9.60M in funding over 2 rounds. Their latest funding was raised on Sep 20, 2022 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 20, 2022 Grant $9.60M 1 Bill & Melinda Gates Foundation Detail

Investors

Number of Lead Investors
Number of Investors
1
1
NUVISAN GmbH is funded by 1 investors. Bill & Melinda Gates Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
Bill & Melinda Gates Foundation Yes Grant

Employee Profiles

Number of Employee Profiles
3
NUVISAN GmbH has 3 current employee profiles, including Executive Dietrich Bruchmann
Executive
Executive
Executive

Acquisition

NUVISAN GmbH has acquired 1 organizations. Their most recent acquisition was Essex Pharma Development on Jun 1, 2011. They acquired Essex Pharma Development for 0.

Date Company Name
Industry Acquisition Type Price
Analytics acquisition Detail